Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Mr. Adam Schechter is the Chairman of the Board of Labcorp Holdings Inc, joining the firm since 2013.
What is the price performance of LH stock?
The current price of LH is $266.56, it has increased 0.2% in the last trading day.
What are the primary business themes or industries for Labcorp Holdings Inc?
Labcorp Holdings Inc belongs to Health Care industry and the sector is Health Care
What is Labcorp Holdings Inc market cap?
Labcorp Holdings Inc's current market cap is $21.9B
Is Labcorp Holdings Inc a buy, sell, or hold?
According to wall street analysts, 22 analysts have made analyst ratings for Labcorp Holdings Inc, including 10 strong buy, 14 buy, 5 hold, 0 sell, and 10 strong sell